XOMA Royalty Corp. (XOMA)
25.53
-1.23
(-4.60%)
USD |
NASDAQ |
Feb 27, 16:00
25.66
+0.13
(+0.51%)
After-Hours: 20:00
XOMA Royalty Research and Development Expense (TTM) : 2.295M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Rezolute, Inc. | 63.64M |
| DiaMedica Therapeutics, Inc. | 24.38M |
| Gossamer Bio, Inc. | 161.14M |